Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs) EQUITY
$111.96
pos +0.00
+0.00%
Today's Range: 111.44 - 112.53 | JNJ Avg Daily Volume: 7,097,800
Last Update: 12/02/16 - 4:00 PM EST
Volume: 0
YTD Performance: 9.00%
Open: $0.00
Previous Close: $111.38
52 Week Range: $94.28 - $126.07
Oustanding Shares: 2,720,531,728
Market Cap: 303,012,823,865
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 7 7
Moderate Buy 2 2 2 2
Hold 9 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.26 2.16 2.22 2.22
Latest Dividend: 0.80
Latest Dividend Yield: 2.87%
Dividend Ex-Date: 11/18/16
Price Earnings Ratio: 19.54
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
19.54 19.70 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-6.17% 9.71% 18.75%
GROWTH 12 Mo 3 Yr CAGR
Revenue -5.70 0.00 0.01
Net Income -5.60 0.50 0.13
EPS -3.90 0.40 0.12
Earnings for JNJ:
EBITDA 22.04B
Revenue 70.07B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.56 $1.76 $6.71 $7.06
Number of Analysts 11 5 12 13
High Estimate $1.62 $1.85 $6.75 $7.25
Low Estimate $1.54 $1.67 $6.70 $6.78
Prior Year $1.44 $1.68 $6.20 $6.71
Growth Rate (Year over Year) 8.27% 5.00% 8.25% 5.18%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
This stock needs more aggressive buying before it is an outright long.
Bearish
Nov 29, 2016 | 7:45 AM EST
JNJ was downgraded from Overweight to Equal-weight, Barclays said. Valuation call, based on a $125 price target.
The U.S. dollar weakened. Crude oil rose by $1.23 to $47.29 on conflicting OPEC reports. Gold climbed by about $12 per ounce to above $1,190 (it had been up $18 earlier). Agricultural commodities were mixed: Wheat down $0.02, corn flat, soybean up $0.12 (continuing its monster run in price) and oats down $0.06. Lumber up $3. Bonds were lower in yield and higher in price. The 10-year yield dropped by five basis points and the long bond by three basis points. The 2s/10s spread declined by three basis points as the yield curve flattened. Municipals flat-lined. Closed-end muni-bond funds recovered a bit. Junk bonds slightly higher. Blackstone/GSO Strategic Credit Fun (BGB) was flat. Banks got clipped. But brokerages were slightly higher. Insurance profit-taking after a big run. Retail was on sale with Nordstrom (JWN) , Home Depot (HD) , Best Buy (BBY) , Target (TGT) and JC Penney (JCP) weak. Autos lower. According to J.D. Power, incentives are at near-record levels. Not good for profits/margins. Biotech down 1.5% (Celgene (CELG) and Gilead Sciences (GILD) off a beaner each), but spec biotech (e.g. Intrexon (XON) , Portola Pharmaceuticals (PTLA)  , SAGE (SAGE)  , Aerie Pharmaceuticals (AERI) ) weak. Big pharma continues to weaken, led by Merck (MRK)  , Bristol-Myers Squibb (BMY)  , Eli Lilly (LLY)
Technical support and statistical evidence suggest the stock will rebound.
The market remains resistant. Brokerages and banks hang in strongly. The Russell Index is killing the shorts -- up ($0.75), again. Retail is experiencing another leg to the upside. JC Penney (JCP) , Home Depot (HD) , Lowe's (LOW) , Best Buy (BBY) , Target (TGT
But don't buy blindly. There are too many companies that can be retaliated against.

My Takeaways and Observations Real Money Pro($)

The U.S. dollar strengthened meaningfully. Any more strength will begin to raise concerns about multinational profits. The price of crude oil expanded by $0.80 to nearly $45/barrel. But, we are still in a short term downtrend. Gold fell be $23. I rebuilt my GLD position on the weakness. We are near the 200 day moving average. Ag commodities: wheat down $0.04, corn down $0.02, soybeans up $0.08 and oats are flat. Fertilizer stocks traded well today. Lumber up $1. Bonds got schmeissed. iShares Barclays 20+ Yr Treas.Bond ETF (TLT) down a beaner. The 10-year U.S. note yield rose by four basis points and the long bond by three basis points. The 2s/10s spread widened by two basis points to 101 basis points. Municipals were surprisingly weaker. Closed end muni bond funds flatlined. But high yield was much stronger iShares iBoxx $ High Yid Corp Bond ETF (HYG) +$1 and SPDR Barclays Capital High Yield Bnd ETF (JNK) +$0.40. Blackstone/GSO Strategic Credit Fund (BGB) +$0.13. Banks benefited from the steepening yield curve. I shorted JPMorgan Chase (JPM) , Citigroup (C) and Financial Select Sector SPDR Fund (XLF) late in the day. Insurance stocks were terrific. Long Hartford Financial (HIG) (large) looks like it might be breaking out. (I still owe you guys an analysis of the good quarter release from last week -- coming soon! Small shorts in Lincoln National (LNC) and Metlife (MET) , rose. Brokerages Morgan Stanley (MS) and Goldman Sachs (GS) were the "world's fair." Autos advanced. I remain short (small) General Motors (GM) and Ford (F) . Retail rebounded. My only long JC Penney (JCP) was punk (up a dime after being up three times that amount earlier in the day). Biotech was +3.5%. Allergan (AGN) , Celgene (CELG) ++ Speculative biotech (Portola Pharmaceuticals (PTLA)  , SAGE Therapeutics (SAGE) , Aerie Pharmaceuticals (AERI) ,  Nektar Therapeutics (NKTR
After the election passes we are going to talk about companies again -- and these have done well.

Columnist Conversations

Shares of UPS are looking a bit vulnerable.  The stock's post election rally has stalled near $117.00.&nb...
As a technician, I look for trends and patterns that repeat over and over again. Some are more reliable than o...
Market looks like it will open ever so slightly down after an inline Jobs report that saw "official" unemploym...
There was nothing in today's November jobs report that should divert its path toward an expected interest rate...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.